1) epithelial membrane antigen
上皮细胞膜抗原
1.
Expression of epithelial membrane antigen in renal cell carcinoma and transitional cell carcinoma of renal pelvis;
上皮细胞膜抗原在肾细胞癌和肾盂移行细胞癌中的表达
3) The membrane of epithelial cell
上皮细胞膜
4) epithelial membrane antigen(EMA)
上皮膜抗原
1.
Methods Serum CA125,CA19-9,CA72-4 and epithelial membrane antigen(EMA) contents were measured with ELISA in 80 patients with ovarian cancer and 50 controls.
目的:探讨血清CA125、CA19-9、CA72-4和上皮膜抗原(EMA)联检对卵巢癌的诊断价值。
5) epithelial membrane antigen
上皮膜抗原
1.
Diagnosis value of epithelial membrane antigen immunocytochemistry examination in meningeal carcinomatosis;
上皮膜抗原免疫细胞化学检查在脑膜癌病中的诊断价值
2.
Objective:To observe the differential expression of epithelial membrane antigen(EMA)and renal cell carcinoma marker(RCC-Ma)in early renal carcinoma and corresponding adjacent(0.
0cm组织上皮膜抗原(epithelial membrane antigen,EMA)、肾细胞癌标志物(renal cell carcinoma marker,RCC-Ma)的表达差异,初步探讨早期肾癌行肾部分切除术时的安全切除边距。
6) EMA
上皮膜抗原
1.
Methods Immunohistochemical method was adopted to detect cytokeratin pan(CK)、Epithelial Membrane Antigen(EMA) and Carcinoembryonic Antigen(CEA) in 389 lymph nodes from 36 cases of breast cancer, in which conventional pathological diagnosis showed no lymph node metastasis.
方法采用免疫组织化学方法,用细胞角蛋白CK、上皮膜抗原EMA、癌胚抗原CEA检测36例常规病理检查无淋巴结转移的腋窝淋巴结389枚。
2.
Objective To investigate the expression of EMA and EGP-2 in breast carcinoma tissues, to analyze their relationship with clinical indexes and to observe the correlation with their expression.
目的通过检测上皮膜抗原(EMA)、表皮糖蛋白基因(EGP-2)在乳腺癌组织中的表达,分析它们与乳腺癌临床病理指标的关系,并研究两者表达的相关性。
3.
Objective:This article is to research on EMA s expression in the esophageal squamous cell carcinomas,to analyze the relationship among cell differentiation degree,the tumor in filtrated depth and lymph node metastasis and to study its relationship with the expression of CK.
目的:研究食管鳞癌组织中上皮膜抗原(epithelial memberane antigen,EMA)的表达,探讨其与食管鳞癌临床病理因素的关系及其与细胞角蛋白(cytokeratin,CK)表达的相关性。
补充资料：鳞状上皮细胞癌抗原
鳞状上皮细胞癌抗原
1977年首次从子宫颈鳞状上皮细胞癌中分离出来的一种分子量为48000的糖蛋白，有很高的特异性，是外阴、阴道、子宫颈鳞状上皮细胞癌最有效和敏感的标志物。在化疗开始治疗2～3个月时，便可由血清SCE水平上升或下降得到病情变化的信息。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条